Genomic biomarkers in prostate cancer

about

Genomic biomarkers in prostate cancer

Item

http://www.wikidata.org/entity/Q57112354

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

Genomic biomarkers in prostate cancer

@en

Genomic biomarkers in prostate cancer

@nl

type

Item

label

Genomic biomarkers in prostate cancer

@en

Genomic biomarkers in prostate cancer

@nl

prefLabel

Genomic biomarkers in prostate cancer

@en

Genomic biomarkers in prostate cancer

@nl

P1476

Genomic biomarkers in prostate cancer

@en

P2093

Daniel E Spratt

http://www.w3.org/2001/XMLSchema#string

Felix Y Feng

http://www.w3.org/2001/XMLSchema#string

Matthew R Cooperberg

http://www.w3.org/2001/XMLSchema#string

Zachary Kornberg

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.

Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer.

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.

P304

459-471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TAU.2018.06.02

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30050804

http://www.w3.org/2001/XMLSchema#string

P921

urology

reproductive medicine

biomarker

P932

6043739

http://www.w3.org/2001/XMLSchema#string

Genomic biomarkers in prostate cancer

about

Genomic biomarkers in prostate cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932